Cara Therapeutics Inc. (NASDAQ: CARA)
$0.37
+0.0350 ( +10.45% ) 974.1K
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
Market Data
Open
$0.37
Previous close
$0.34
Volume
974.1K
Market cap
$20.23M
Day range
$0.33 - $0.38
52 week range
$0.24 - $3.45
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 18, 2024 |
8-k | 8K-related | 15 | Jun 12, 2024 |
8-k | 8K-related | 14 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 91 | May 13, 2024 |